191 related articles for article (PubMed ID: 21722022)
1. Motivators of enrolment in HIV vaccine trials: a review of HIV vaccine preparedness studies.
Dhalla S; Poole G
AIDS Care; 2011 Nov; 23(11):1430-47. PubMed ID: 21722022
[TBL] [Abstract][Full Text] [Related]
2. Motivators to participation in actual HIV vaccine trials.
Dhalla S; Poole G
AIDS Behav; 2014 Feb; 18(2):263-77. PubMed ID: 23736885
[TBL] [Abstract][Full Text] [Related]
3. Barriers of enrolment in HIV vaccine trials: a review of HIV vaccine preparedness studies.
Dhalla S; Poole G
Vaccine; 2011 Aug; 29(35):5850-9. PubMed ID: 21740947
[TBL] [Abstract][Full Text] [Related]
4. Motivators to participation in medical trials: the application of social and personal categorization.
Dhalla S; Poole G
Psychol Health Med; 2013; 18(6):664-75. PubMed ID: 23360313
[TBL] [Abstract][Full Text] [Related]
5. An update on human immunodeficiency virus vaccine preparedness studies.
Dhalla S
J Med Microbiol; 2015 Jul; 64(7):731-738. PubMed ID: 25908608
[TBL] [Abstract][Full Text] [Related]
6. Contextualizing willingness to participate: recommendations for engagement, recruitment & enrolment of Kenyan MSM in future HIV prevention trials.
Doshi M; Avery L; Kaddu RP; Gichuhi M; Gakii G; du Plessis E; Dutta S; Khan S; Kimani J; Lorway RR
BMC Public Health; 2017 May; 17(1):469. PubMed ID: 28521748
[TBL] [Abstract][Full Text] [Related]
7. Volunteer motivators for participating in HIV vaccine clinical trials in Nairobi, Kenya.
Nyaoke BA; Mutua GN; Sajabi R; Nyasani D; Mureithi MW; Anzala OA
PLoS One; 2017; 12(9):e0183788. PubMed ID: 28880880
[TBL] [Abstract][Full Text] [Related]
8. HIV vaccine trial preparedness among Spanish-speaking Latinos in the US.
Brooks RA; Newman PA; Duan N; Ortiz DJ
AIDS Care; 2007 Jan; 19(1):52-8. PubMed ID: 17129857
[TBL] [Abstract][Full Text] [Related]
9. Altruism motivates participation in a therapeutic HIV vaccine trial (CTN 173).
Balfour L; Corace K; Tasca GA; Tremblay C; Routy JP; Angel JB
AIDS Care; 2010 Nov; 22(11):1403-9. PubMed ID: 20936540
[TBL] [Abstract][Full Text] [Related]
10. Selectively willing and conditionally able: HIV vaccine trial participation among women at "high risk" of HIV infection.
Voytek CD; Jones KT; Metzger DS
Vaccine; 2011 Aug; 29(36):6130-5. PubMed ID: 21704110
[TBL] [Abstract][Full Text] [Related]
11. HIV vaccine preparedness studies in the non-organization for economic co-operation and development (non-OECD) countries.
Dhalla S; Nelson KE; Singer J; Poole G
AIDS Care; 2009 Mar; 21(3):335-48. PubMed ID: 18781449
[TBL] [Abstract][Full Text] [Related]
12. Reported willingness to participate in a hypothetical HIV vaccine trial and its translation to actual participation among healthy adults-Experience from Kenya.
Nyasani DK; Mutua GN; Sajabi RM; Ng'ang'a JW; Gachie JN; Maina AM; Lusike LL; Anzala AO; Price MA; Manyonyi GO
PLoS One; 2018; 13(11):e0206656. PubMed ID: 30388145
[TBL] [Abstract][Full Text] [Related]
13. Motivators and barriers influencing willingness to participate in candidate HCV vaccine trials: perspectives of people who inject drugs.
Park JN; White B; Bates A; Enriquez J; Liao L; Maher L
Drug Alcohol Depend; 2012 Jun; 123(1-3):35-40. PubMed ID: 22071117
[TBL] [Abstract][Full Text] [Related]
14. HIV vaccine trial participation among ethnic minority communities: barriers, motivators, and implications for recruitment.
Newman PA; Duan N; Roberts KJ; Seiden D; Rudy ET; Swendeman D; Popova S
J Acquir Immune Defic Syndr; 2006 Feb; 41(2):210-7. PubMed ID: 16394854
[TBL] [Abstract][Full Text] [Related]
15. Does message framing predict willingness to participate in a hypothetical HIV vaccine trial: an application of Prospect Theory.
Evangeli M; Kafaar Z; Kagee A; Swartz L; Bullemor-Day P
AIDS Care; 2013; 25(7):910-4. PubMed ID: 23216424
[TBL] [Abstract][Full Text] [Related]
16. Age and sex or gender (sex/gender) and HIV vaccine preparedness.
Dhalla S
Psychol Health Med; 2016 Jun; 21(4):505-524. PubMed ID: 26515031
[TBL] [Abstract][Full Text] [Related]
17. Willingness to participate in HIV vaccine efficacy trials among high risk men and women from fishing communities along Lake Victoria in Uganda.
Asiki G; Abaasa A; Ruzagira E; Kibengo F; Bahemuka U; Mulondo J; Seeley J; Bekker LG; Delany S; Kaleebu P; Kamali A
Vaccine; 2013 Oct; 31(44):5055-61. PubMed ID: 24021306
[TBL] [Abstract][Full Text] [Related]
18. Barriers to participation in actual HIV vaccine trials.
Dhalla S; Poole G
Curr HIV Res; 2013 Apr; 11(3):238-45. PubMed ID: 23721228
[TBL] [Abstract][Full Text] [Related]
19. Motivations to participate in a Phase I/II HIV vaccine trial: A descriptive study from Dar es Salaam, Tanzania.
Tarimo EA; Bakari M; Kakoko DC; Kohi TW; Mhalu F; Sandstrom E; Kulane A
BMC Public Health; 2016 Feb; 16():182. PubMed ID: 26911203
[TBL] [Abstract][Full Text] [Related]
20. Readiness of high-risk populations in the HIV Network for Prevention Trials to participate in HIV vaccine efficacy trials in the United States.
Koblin BA; Heagerty P; Sheon A; Buchbinder S; Celum C; Douglas JM; Gross M; Marmor M; Mayer K; Metzger D; Seage G
AIDS; 1998 May; 12(7):785-93. PubMed ID: 9619811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
